Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 6, 2007, Pages

  Myers, Brent ^a   Greenwood Van Meerveld, Beverley ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Corticosterone; Hypothalamic pituitary adrenal axis; Irritable bowel syndrome

Indexed keywords

CHOLESTEROL; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ABDOMINAL WALL MUSCULATURE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; COLON; CONTROLLED STUDY; MALE; MAZE TEST; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; ANXIETY; BALLOON DILATATION; BEHAVIOR, ANIMAL; COLON; DRUG IMPLANTS; HORMONE ANTAGONISTS; HYDROCORTISONE; HYPERALGESIA; IRRITABLE BOWEL SYNDROME; MALE; MIFEPRISTONE; MUSCLE CONTRACTION; PRESSURE; RATS; RATS, INBRED F344; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; SENSATION; SPIRONOLACTONE;

EID: 34447530937     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00080.2007     Document Type: Article

References (45)

1. Baklavadzhyan OG, Pogosyan NL, Arshakyan AV, Darbinyan AG, Khachatryan AV, Nikogosyan TG. Studies of the role of the central nucleus of the amygdala in controlling cardiovascular functions. Neurosci Behav Physiol 30: 231-236, 2000.
2. Beaulieu S, Pelletier U, Vandry M, Barden N. Influence of the central nucleus of the amygdala on the content of corticotrophin-releasing factor in the median eminence. Neuroendocrinology 49: 255-261, 1989.
3. Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas J, Fournet J, Segebarth C. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol 97: 654-661, 2002.
4. Cadepond F, Ulmann A, Baulieu E, RU. 486 (mifepristone): mechanisms of action, and clinical uses. Annu Rev Med 48: 129-156, 1997.
5. Delyani JA. Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney Int 57: 1408-1411, 2000.
6. De Kloet ER, Reul JM. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12: 83-105, 1987.
7. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269-301, 1998.
8. De Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6: 463-75, 2005.
9. De Olmos JS, Heimer L. The concepts of the ventral striatopallidal system and extended amygdala. Ann NY Acad Sci 877: 1-32, 1987.
10. Dinan T, Quigley E, Ahmed S, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling P. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130: 304-311, 2006.
11. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE,. Psychosocial aspects of the functional gastrointestinal disorders. Gut 45: II25-II30, 1999.
12. Feldman S, Weidenfeld J. The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res Bull 45: 389-393, 1998.
13. Gagne D, Pons M, Philibert D. RU 38486: a potent antiglucocorticoid in vitro and in vivo. J Steroid Biochem 23: 247-251, 1985.
14. Glowa J, Hansen C. Differences in response to an acoustic startle stimulus among forty-six rat strains. Behav Genet 24: 79-84, 1994.
15. Greenwood-Van Meerveld B, Gibson M, Gunter W, Shepard J, Foreman R, Myers D. Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats. Brain Res 893: 135-142, 2001.
16. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 17: 415-422, 2005.
17. Gunter W, Shepard JD, Foreman RD, Myers DA, Greenwood-Van Meerveld B. Evidence for visceral hypersensitivity in high-anxiety rats. Physiol Behav 69: 379-382, 2000.
18. Harper RM, Frysinger RC, Trelease RB, Marks JD. State-dependent alteration of respiratory cycle timing by stimulation of the central nucleus of the amygdala. Brain Res 306: 1-8, 1984.
19. Krettek JE, Price JL. The cortical projections of the mediodorsal nucleus and adjacent thalamic nuclei in the rat. J Comp Neurol 171: 157-191, 1977.
20. Kovacs KJ, Makara GB. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res 474: 205-210, 1988.
21. Kovacs K, Kiss JZ, Makara GB. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotrophin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 44: 229-234, 1986.
22. LeDoux JE, Iwata J, Cicchetti P, Reis DJ. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 8: 2517-2529, 1988.
23. Lyubashina OA. Possible mechanisms of involvement of the amygdaloid complex in the control of gastric motor function. Neurosci Behav Physiol 34: 379-388, 2004.
24. Marver D. Assessment of mineralocorticoid activity in the rabbit colon. Am J Physiol Renal Fluid Electrolyte Physiol 246: F437-F446, 1984.
25. McDonald TJ, Hoffman GE, Myers DA, Nathanielsz PW. Hypothalamic glucocorticoid implants prevent fetal ovine adrenocorticotropin secretion in response to stress. Endocrinology 127: 2862-2868, 1990.
26. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 109: 40-52, 1995.
27. Munck A, Naray-Fejes-Toth A. The ups and downs of glucocorticoid physiology: permissive and suppressive effects revisited. Mol Cell Endocrinol 90: C1-C4, 1992.
28. Naliboff B, Berman S, Chang L, Derbyshire S, Suyenobu B, Mayer E. Sex-related differences in IBS patients: central processing of visceral stimuli. Gastroenterology 124: 1738-1747, 2003.
29. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res 450: 153-169, 1988.
30. Nobel S, Abrahmsen L, Oppermann U. Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones. Eur J Biochem 268: 4113-4125, 2001.
31. Ogle TF, Beyer BK. Steroid-binding specificity of the progesterone receptor from rat placenta. J Steroid Biochem 16: 147-150, 1982.
32. Pace T, Spencer R. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am J Physiol Endocrinol Metab 288: E1082-E1088, 2005.
33. th ed.). New York: Academic, 1998.
34. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167, 1985.
35. Qin C, Greenwood-Van Meerveld B, Myers DA, Foreman RD. Corticosterone acts directly at the amygdala to alter spinal neuronal activity in response to colorectal distension. J Neurophysiol 89: 1343-1352, 2003.
36. Reul J, de Kloet R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511, 1985.
37. Rosen JB, Schulkin J. From normal fear to pathological anxiety. Psychol Rev 205: 325-350, 1998.
38. 3H]corticosterone receptors in rat brain. Brain Res 271: 331-334, 1983.
39. Shepard JD, Barron KW, Myers DA. Corticosterone delivery to the amygdala increases corticotrophin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861: 288-295, 2000.
40. Shepard JD, Barron KW, Myers DA. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res 963: 203-213, 2003.
41. Sica DA. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Failure Rev 10: 23-29, 2005.
42. Spencer RL, Young EA, Choo PH, McEwen BS. Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res 514: 37-48, 1990.
43. Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes K, Anthony J, Shabsin H, Schuster M. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 98: 1187-1192, 1990.
44. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on the bowel symptoms: subjects with irritable bowel syndrome compared with subjects without irritable bowel dysfunction. Gut 30: 825-830, 1992.
45. Wilder-Smith C, Schindler D, Lovblad K, Redmond S, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut 53: 1595-1601, 2004.